085V0ZZ
Destruction Lacrimal Gland, Right to No Qualifier with No Device, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 8 Eye |
| Operation | 5 Destruction |
| Body Part | V Lacrimal Gland, Right |
| Approach | 0 Open |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers procedures that permanently eliminate abnormal or diseased eye tissue using energy, heat, cold, or a chemical agent, without physically removing the tissue from the body. Common examples include laser photocoagulation to seal or destroy abnormal retinal blood vessels in diabetic eye disease or age-related macular degeneration, cyclophotocoagulation to reduce fluid-producing tissue inside the eye as a glaucoma treatment, and cryotherapy or laser treatment of retinal tears to prevent detachment.
These treatments are chosen when the goal is to stop a harmful process at its source, such as leaking vessels or overactive tissue, rather than to excise a specimen for examination. Because the destroyed tissue is left in place to be reabsorbed by the body, these procedures are often less invasive than a comparable excision and can frequently be performed in an outpatient or office laser suite.
Anatomy & Axis Detail
Lacrimal Gland, Right
The right lacrimal gland sits in the superolateral orbit and produces the aqueous component of tears; it is targeted for destruction in cases of gland tumor debulking when excision is not feasible, chronic refractory dacryoadenitis, or select cases of severe reflex tearing where reducing secretory tissue is the therapeutic goal. Because the gland lies deep within the orbital rim beneath the lateral brow, destructive approaches such as electrocautery or laser ablation are usually performed through an anterior orbitotomy or transconjunctival approach rather than percutaneously. Proximity to the levator aponeurosis, lateral rectus muscle, and orbital fat means the procedure carries risk to eyelid function and globe motility if imprecise. Documentation should reflect that gland tissue was destroyed in place, distinguishing this from partial or total excision of the gland.
Approach: Open
Open approach means the surgeon cuts through skin, mucous membrane, or other tissue layers to physically expose the target site to view before performing the procedure. It gives direct visualization and hands-on access, distinguishing it from Percutaneous approaches where instruments pass through a small puncture without exposing the site. Open is typical for procedures needing wide access, such as most laparotomies.
Coding & Documentation
Documentation needs to specify the energy source or agent used, such as laser, cryotherapy probe, or a chemical, and the exact eye structure targeted, since destruction codes in this system are organized by precise anatomical site down to structures like the retina, choroid, or ciliary body. Coders should confirm the intent recorded by the surgeon was ablation or eradication of tissue rather than biopsy or removal of a specimen, because any tissue sent to pathology signals an Excision instead. A recurring error is coding panretinal photocoagulation or focal laser treatments to a generic retina code when the note actually distinguishes treatment areas that map to different body part values.